Explore molecular regulatory events driving malignant melanoma progression, drawing on decades of translational research spanning prognostic biomarkers, cell-free DNA, and the tumor microenvironment. Dr. Hoon's recent work examines how the tumor microenvironment of primary and metastatic melanomas contributes to disease progression and resistance to immunotherapy.
UCI SKIN SEMINAR SERIES, Presented by Cancer Center Biotechnology, Imaging & Drug Development Research Program; Department of Dermatology; UCI Skin Working Group
|
